Pepdox
Studies
Peptides
Calculator
In overweight or obese adults without diabetes, semaglutide increased weight loss and GI disorders. | Pepdox
Home
/
Search
/
PMID 34224258
In overweight or obese adults without diabetes, semaglutide increased weight loss and GI disorders.
Annals of internal medicine
2021
PMID: 34224258
View on PubMed
DOI: 10.7326/ACPJ202107200-080
Semaglutide
Abstract
Wilding JPH, Batterham RL, Calanna S, et al.N Engl J Med. 2021;384:989. 33567185.
Authors
Rajagopal, Selvi; Cheskin, Lawrence J